← Leaderboards
Scott Burwell
Neurotype Inc.
$1,060,546
Attributed
$1,060,546
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $655.6K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,060,546 · 3
By mechanism
R43$731,583 · 2
R44$328,963 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Relapse”
- Andrew S Huhn · Johns Hopkins University$14,832,590
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Gonul Velicelebi · Sanford Burnham Prebys Medical Discovery Institute$8,970,452
- Gary Fanger · Rise Therapeutics, Llc$8,202,376
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$6,841,955
- Jeffrey Benner · Drug Delivery Company, Llc, The$6,616,062
Research focus
RelapseMonitorPoint Of CareUnited States Food And Drug AdministrationCravingCuesPharmaceutical PreparationsDrug UsageSmall Business Innovation Research GrantDrug CravingOpioid Use DisorderMeetingsOpioidBrainFeedbackBiological MarkersBenchmarkingClinical TrialsNeurosciencesImageComputer SoftwareInnovationCostAddiction
Grant awards (5)
Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials$328,963
R44 · FY2023 · DA · contact PI
Closed-loop attention bias modification brain training for opioid use disorder$326,672
R43 · FY2023 · DA · contact PI
Mobile brain sensing platform for detection of opioid craving and treatment response$114,916
R43 · FY2021 · DA · contact PI
Mobile brain sensing platform for detection of opioid craving and treatment response$54,911
R43 · FY2021 · DA · contact PI
Mobile brain sensing platform for detection of opioid craving and treatment response$235,084
R43 · FY2020 · DA · contact PI